FindTrial
Sign In

Comparison between 0.5% Ropivacaine and in combination with Dexmedetomidine for ultrasound guided Supraclavicular brachial plexus block for upper limb surgery.

A study to compare the anaesthetic properties of 0.5% Ropivacaine alone and in combination with Dexmedetomidine for ultrasound guided Supraclavicular brachial plexus block in patients undergoing upper limb surgery. - SCBPB

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017309
Enrollment
100
Registered
2019-01-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ultrasound guided SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK.: Time of onset of block is assessed and duration of study is around 1 year. Control Intervention1: 0.5% isobaric Ropivacaine alo

Sponsors

JLN MEDICAL COLLEGE AJMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group between 15 and 65 years. Body weight 30 to 80 kg. Patients belonging to ASA (American Society of Anaesthesiologists) class-I and II. Patients undergoing upper limb surgeries of duration 1-2 hours in theatre with haemoglobin at least 9 gm/dl. Patient free from any associated acute or chronic systemic illness.

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the study. Uncooperative patients. Patient with chronic pain or on long-term analgesics. Any known hypersensitivity or contraindication to ropivacaine, dexmedetomidine. Local pathology at the site of injection or disability limiting the performance of block. Patients receiving beta blockers or cardiac drugs. History of convulsion, allergy to the drug used, bleeding disorder, severe neurological deficit, thyroid disorder. Patient with history of respiratory, cardiac, hepatic or renal disease (necessitating classification in ASA Class III or above). Patients having a history of significant neurological, psychiatric, or neuromuscular disorders. Pregnant, lactating mothers. Inadequate block necessitating institution of general anaesthesia for continuation of surgical procedure.

Design outcomes

Primary

MeasureTime frame
To assess and compare the onset, duration and highest grade of sensory block. To assess and compare the onset, duration and highest grade of motor block. To assess and compare the total duration of effective analgesia by visual analog scale (VAS). To assess and compare the peri-operative sedation Score.Timepoint: Duration of study is around 1 year.—

Secondary

MeasureTime frame
To assess and compare the quality of anaesthesia. 2. To assess and compare the hemodynamic changes if any. 3. To assess and compare the proportion of patient having adverse effects and any other complications.Timepoint: Duration of study is around 1 year—

Countries

India

Contacts

Public ContactDr Kavita Jain

Jawahar lal nehru medical college, ajmer, rajasthan

drkavitajain15@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026